Switching From MEDVi to Ro: 7-Step Plan + 2026 Cost Checklist
By WPG Research Team · Published · Last verified:
We earn a referral fee when readers start with Ro or MEDVi through our links. This does not change our editorial conclusions — we tell readers when MEDVi is the better fit even though Ro pays us more on cash-pay traffic.
Medical note: This page is for education. A licensed clinician decides whether a GLP-1 medication, dose, or switch is right for you. Do not combine, overlap, restart, or change GLP-1 medications without clinician direction.
Switching from MEDVi to Ro is a smart move if you want FDA-approved medication, help getting your insurance to cover it, or one of the newer options Ro now carries — Wegovy® pill, Foundayo® (orforglipron), Zepbound® KwikPen, or Wegovy® pen. But the order matters. Do not cancel MEDVi first. Start your Ro intake while you are still on MEDVi. Save your dose history. Then cancel MEDVi at least 72 hours before your next billing date so you don't get charged again. Ro costs $39 your first month, then $149/month (as low as $74/month with annual prepay), with medication billed separately. If you have commercial insurance and eligible manufacturer savings apply, certain medication can be as low as $25/month. Cash-pay options start at $149/month for the Wegovy® pill 1.5 mg or Foundayo® 0.8 mg.
Should You Switch? The 30-Second Verdict
| ✅ Switch to Ro if… | ⏸ Stay with MEDVi if… | 🔀 Compare other providers if… |
|---|---|---|
| You want FDA-approved medication, insurance help with prior authorization, or the new Wegovy® pill / Foundayo® / Zepbound® KwikPen options | Your top priority is the lowest all-in cash-pay price ($299/month flat works) and your current plan is solving the problem | You want oral compounded options, no membership model, a different support style, or you're not sure Ro is the right move |
| ⬇ Continue below — we'll walk you through it | Read our honest MEDVi review → | Take the 60-second matching quiz → |
What Actually Changes When You Switch From MEDVi to Ro
The short answer: Three things change. Your medication moves from compounded semaglutide or tirzepatide to FDA-approved options like Wegovy®, Zepbound®, Foundayo®, or Ozempic® (off-label). Your pricing splits into a membership fee plus medication billed separately, instead of MEDVi's flat all-in price. And you gain Ro's insurance concierge, which submits prior authorization paperwork to fight for commercial insurance coverage.
Side-by-side verified May 12, 2026
| What you'll experience | MEDVi (where you are now) | Ro (where you're going) |
|---|---|---|
| Medication type | Compounded semaglutide or tirzepatide. Compounded drug products are not FDA-approved as finished products. | FDA-approved Wegovy® pen, Wegovy® pill, Zepbound® KwikPen, Zepbound® vial, Foundayo®, plus Ozempic® off-label. Ro's terms note members may be prescribed compounded medication during national drug shortages. |
| First-month cost | $179 (compounded semaglutide) | $39 Ro Body membership + medication billed separately |
| Ongoing cost (cash, no insurance) | $299/month flat (semaglutide) | $149/month membership ($74/month with annual prepay) + medication ($149–$449+/month depending on drug and dose) |
| Uses your insurance | No | Membership is cash. Ro's insurance concierge fights to get your commercial insurance to cover the medication. With eligible commercial insurance and manufacturer savings, certain medication can be as low as $25/month. |
| HSA / FSA | Check during MEDVi checkout | Check during Ro checkout |
| Time to first dose | 3–7 days (cash, async) | Ro says you'll know if you're eligible within 2 days. Cash route: less than a week once prescribed. Insurance route: 2–3 weeks for prior authorization. |
| Cancellation notice required | 72 hours before your next billing date | 48 hours before your next renewal |
| What's in the membership | Provider review, plan, medication, refills — bundled into one price | Provider check-ins, included Quest lab testing when ordered, insurance concierge, coaching, app access. Medication is billed separately. |
⚠️ One honest catch — here's where most readers get tripped up
Ro is not automatically cheaper than MEDVi. On cash-pay with no insurance benefit, switching to Ro will cost you roughly $1,500 to $2,300 more per year at typical maintenance doses. If your only goal is the lowest monthly bill and you have no insurance, MEDVi is still the cheaper path.
That's the honest tradeoff. We're putting it here, on the first scroll, so you can't miss it.
But you're not switching for the price. You're switching because:
- You want medication you can verify on the FDA label
- You want someone to fight your insurance for you instead of doing it alone in PDF hell
- You want Wegovy® pill or Foundayo® — daily pills with FDA-reviewed dosing
- You want a clearer regulatory footing after the FDA's 30-letter wave in March 2026
Why People Are Switching From MEDVi to Ro Right Now
The short answer: Three things happened in early 2026 that pushed a lot of MEDVi customers to switch. The FDA sent MEDVi a warning letter on February 20, 2026. The FDA then sent 30 warning letters to telehealth companies on March 3, 2026. And new FDA-approved options launched on Ro — Wegovy® pill (December 2025), Zepbound® KwikPen (April 2026), and Foundayo® (FDA-approved April 1, 2026) — that didn't exist a year ago and are now priced within reach of many cash-pay buyers for the first time.
The February 2026 FDA Warning Letter to MEDVi (What It Actually Said)
On February 20, 2026, the FDA sent MEDVi a public warning letter (Letter #721455). The letter flagged two specific issues:
- MEDVi's website labeled compounded products with "MEDVi" branding in a way that suggested MEDVi was the compounder — when in fact MEDVi is not the compounder.
- MEDVi's site used the phrase "same active ingredient as Wegovy® and Ozempic®" for its compounded products. The FDA called this misleading because compounded drug products are not FDA-approved or evaluated for safety and effectiveness.
What the letter IS
What the letter is NOT
The March 3, 2026 Wave of 30 Warning Letters
A few weeks after the MEDVi letter, the FDA announced 30 warning letters to telehealth companies for false or misleading claims about compounded GLP-1 products — including claims implying sameness with FDA-approved products and obscuring product sourcing. This was not a one-off. The FDA has clarified restrictions on compounding products that are essentially copies of commercially available products, and the regulator is moving against misleading compounded-GLP-1 marketing.
Why Ro Became a Much Better Option in the Last 12 Months
A year ago, Ro was the "for people with good insurance" provider. The cash-pay options weren't competitive with MEDVi. That has changed:
- Wegovy® pill — FDA-approved December 2025. A daily oral tablet of semaglutide. Through Ro, the 1.5 mg dose is $149/month. The 4 mg dose is $199/month (was $149 through April 15, 2026). The 9 mg and 25 mg doses are $299/month. Novo Nordisk reported 16.6% mean weight loss in the OASIS 4 trial when treatment was adhered to.
- Foundayo® (orforglipron) — FDA-approved April 1, 2026. The first non-peptide oral GLP-1. Can be taken any time of day, with or without food or water. Through Ro: $149/month for 0.8 mg, $199/month for 2.5 mg, $299/month for 5.5–9 mg, and $299/month for 14.5–17.2 mg with the 45-day refill check-in. In Lilly's ATTAIN-1 trial, people on the highest dose who stayed on treatment lost an average of 27.3 pounds (12.4%) versus 2.2 pounds on placebo.
- Zepbound® KwikPen — launched April 2, 2026. The pen format of tirzepatide. Through Ro: $299/month for 2.5 mg, $399/month for 5 mg, and $449/month for 7.5–15 mg with the 45-day refill check-in. In Lilly's SURMOUNT-1 trial: 15.0% average weight reduction at 5 mg, 19.5% at 10 mg, and 20.9% at 15 mg over 72 weeks.
- Wegovy® pen — promotional pricing of $199/month for starting doses (subject to current Ro promo availability).
What Is the Safest Order for Switching From MEDVi to Ro?
⛔ Critical: Never cancel MEDVi before your Ro plan is in place
Find your next MEDVi billing date
Log into your MEDVi account and find your next billing date. Screenshot it. MEDVi's cancellation policy requires the request to be received at least 72 hours before your next billing date. This one date drives the whole plan.
Save your MEDVi records
Pull together the records a new clinician will need. See the full checklist in the next section.
Complete your Ro Body intake
Go to Ro and start the Body program intake. It takes about 10 minutes — a health questionnaire and an online visit. A Ro-affiliated provider reviews your intake. Ro says you'll know if you're eligible within 2 days. They may message you about your MEDVi dose history. They may order lab work (Quest testing is included when ordered).
Keep your normal MEDVi schedule
Don't take an extra dose. Don't skip a dose. Stay on your normal MEDVi schedule until your Ro plan is in place.
Wait for your Ro prescription
Cash-pay route: Ro says you can take your first dose in less than a week once prescribed. Insurance route: Ro's concierge submits prior authorization — typically takes 2–3 weeks, sometimes longer if denied and appealed. Keep paying for MEDVi during this window. Don't cancel yet.
Cancel MEDVi only after your Ro plan is in place
Once your Ro medication is on the way (or insurance has approved coverage), you've removed the risk of a treatment gap. Cancel at least 72 hours before your next MEDVi billing date — email [email protected] AND use the chat in your patient portal. Screenshot both requests and the confirmations.
Start your Ro medication
Your Ro-affiliated provider sets your start date based on your specific case. Give them the exact date of your last MEDVi dose, your dose amount, the medication format, and your side-effect history. Do not time the switch yourself.
How long the whole switch takes
- Cash-pay route: ~10–14 days from Ro intake to first dose
- Insurance route: ~14–28 days (the prior auth wait is the variable)
What to Save From MEDVi Before You Cancel Anything
The short answer: Save your prescription label, dose history, last-dose date, side-effect notes, pharmacy name, weight trend, lab results, support messages, and your next MEDVi billing date. The goal is not to make Ro continue your exact plan — Ro's clinician decides that. The goal is to give them the information they need to evaluate your dose history.
Walk into your Ro intake with documentation, not a story. Complete records do not guarantee dose continuation — they make the review easier.
Your MEDVi Records Checklist — print and check off:
- Prescription label photo — front of the box, medication name, dose, pharmacy
- Current weekly dose — in mg, exactly (for example, 1.7 mg semaglutide)
- Last dose date — to the day
- Start date with MEDVi — when you began
- Dose change history — what you started at, when you stepped up, current dose
- Side-effect notes — nausea? Tolerable? Severe? Did anything make you skip?
- Current weight — within the last 7 days
- Weight trend — starting weight, current, total loss
- Any lab work — A1c, lipids, kidney function (if available)
- Pharmacy name — listed on your shipping label or box
- Important MEDVi support messages — anything about doses, refills, or issues
- Next MEDVi billing date — screenshot from your account
Copy-Paste Records Request Email (for MEDVi)
Send this to [email protected]:
You're not flagging that you're leaving. You're asking for records — which you have a right to.
How Much Does Switching From MEDVi to Ro Cost in the First 30 Days?
The short answer: Your real first-30-day cost depends on three things: whether you accidentally let MEDVi bill you one more time, which Ro medication you end up on, and whether your insurance covers it. The cheapest realistic scenario is around $188. The expensive scenario is around $487 (you miss the MEDVi cancellation window). Eligible commercial insurance and manufacturer savings can drop the medication cost to as low as $25/month for certain drugs.
| Your scenario | First-30-day total |
|---|---|
| Best case: Cancel MEDVi on time. Ro membership ($39) + cash-pay Wegovy® pill 1.5 mg or Foundayo® 0.8 mg ($149) | ~$188 |
| You miss the 72-hour window: MEDVi bills you ($299) + Ro membership ($39) + cash-pay starting dose ($149) | ~$487 |
| No overlap, mid-range medication: Ro membership ($39) + cash-pay Zepbound® KwikPen 2.5 mg ($299) | ~$338 |
| Insurance + savings: Ro membership ($39) + medication as low as $25 with eligible commercial savings | ~$64 |
Ro Cash-Pay Medication Costs (Verified May 12, 2026)
Add $39 first month, then $149/month ($74/month with annual prepay) on top of these medication prices.
| Medication | Cash-pay price |
|---|---|
| Wegovy® pill 1.5 mg (daily) | $149/month |
| Wegovy® pill 4 mg | $199/month (was $149 through April 15, 2026) |
| Wegovy® pill 9 mg and 25 mg | $299/month each |
| Foundayo® 0.8 mg (daily, no food rules) | $149/month |
| Foundayo® 2.5 mg | $199/month |
| Foundayo® 5.5 mg and 9 mg | $299/month each |
| Foundayo® 14.5 mg and 17.2 mg | $299/month with 45-day refill check-in; $349/month if missed |
| Wegovy® pen | $199/month promo, then $349/month at maintenance |
| Zepbound® KwikPen 2.5 mg | $299/month |
| Zepbound® KwikPen 5 mg | $399/month |
| Zepbound® KwikPen 7.5–15 mg | $449/month with 45-day refill check-in; $499–$699/month if missed |
| Ozempic® without insurance | $900–$1,100/month |
Why Insurance Flips the Math
KFF's 2025 Employer Health Benefits Survey found that 19% of firms with 200+ workers covered GLP-1 agonists primarily for weight loss. Coverage varied by firm size: 16% for firms with 200–999 workers, 30% for firms with 1,000–4,999 workers, and 43% for firms with 5,000+ workers. If your plan is one of them, Ro's concierge handles the prior authorization paperwork. When commercial insurance coverage and eligible manufacturer savings apply, certain medication costs can be as low as $25/month.
Quick Check: When Is Your MEDVi Cancellation Deadline?
- 1.Find your next billing date in your MEDVi account.
- 2.Subtract 3 days. That's your absolute deadline (72 hours).
- 3.Plan to cancel a full week earlier to leave buffer for support response and weekends.
Submit cancellation by email to [email protected] AND through the chat in your patient portal. Screenshot both.
Will Ro Continue Your Dose?
The short answer: Maybe, but don't assume it. A Ro-affiliated provider reviews your dose history, last-dose date, side effects, medication source, and current health information, then decides whether to continue, lower, restart, or change the medication path. Complete records make that review easier — they do not guarantee dose continuation.
What Your Ro Provider Needs to Evaluate Your Dose History
- Your last weekly dose, in milligrams, exactly.
- The date of your last dose, to the day.
- How you tolerated it — manageable nausea, severe side effects, anything that made you skip.
- Your full dose timeline — what you started at, when you stepped up, where you are now.
- Your prescription label with the medication name, dose, and dispensing pharmacy.
- Any lab work you have (A1c, lipids, kidney function).
- Your weight and weight trend — start, current, total loss.
Important: there's no official compounded → FDA-approved conversion chart
What to Ask Ro Before You Finalize Anything
Use this script in your intake or message:
Given that history, would you consider continuing me near my current dose, or do you recommend stepping back?
If I do need to step back, what's the timeline to return to my previous dose?"
Which Ro Medication Might Make Sense After Switching From MEDVi?
Safety reminder
If You Were on a Semaglutide Product at MEDVi — Ask About:
- Wegovy® pen — the FDA-approved semaglutide injection (longest track record)
- Wegovy® pill — the FDA-approved oral semaglutide option (daily, with FDA-reviewed dosing)
- Foundayo® — a different molecule entirely (non-peptide oral GLP-1), no food, water, or timing rules
If You Were on a Tirzepatide Product at MEDVi — Ask About:
- Zepbound® KwikPen — the FDA-approved tirzepatide pen (launched April 2026)
- Zepbound® vials — the cash-pay vial format ($299/month starting via LillyDirect integration)
If You Have Commercial Insurance:
- Ro's concierge typically pursues Wegovy® or Zepbound® first based on what your plan covers
- If denied, the provider may try a clinically appropriate alternative
- With eligible commercial savings, certain medication can be as low as $25/month
If You're 65+ and on Medicare:
Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027)
- Eligible medications: Foundayo®, Wegovy® (injection and tablets), Zepbound® KwikPen
- Flat $50 copay regardless of dose
- Eligibility: Part D/MA-PD enrollment + prior authorization. Three clinical routes: BMI ≥35; BMI ≥30 with heart failure with preserved ejection fraction, uncontrolled hypertension, or chronic kidney disease stage 3a+; or BMI ≥27 with prediabetes, prior MI, prior stroke, or symptomatic peripheral artery disease.
- Note: Ro says it currently can't help coordinate GLP-1 medication coverage for government insurance plans.
| Medication | Published weight-loss data |
|---|---|
| Wegovy® injection 2.4 mg | ~15% average body weight loss in published trials |
| Wegovy® pill 25 mg | 16.6% mean weight loss in OASIS 4 (adherent to treatment) |
| Zepbound® 5 mg (SURMOUNT-1) | 15.0% average at 72 weeks |
| Zepbound® 10 mg (SURMOUNT-1) | 19.5% average at 72 weeks |
| Zepbound® 15 mg (SURMOUNT-1) | 20.9% average at 72 weeks |
| Foundayo® top dose (ATTAIN-1) | 27.3 lbs (12.4%) for those who stayed on treatment |
These are not head-to-head comparisons. Across separate published trials, Zepbound shows the highest average weight-loss numbers and Foundayo's top-dose average is lower — but Foundayo is the only one with no food or timing rules.
Is Ro Available in Your State?
The short answer: Ro operates in most U.S. states, but availability for specific medications can vary by state, pharmacy, and whether you're going cash-pay or insurance. Check during Ro's intake before canceling MEDVi. If a medication you want isn't available where you live, your provider may suggest a clinically appropriate alternative. If nothing fits and you're not ready to stay on compounded, our matching quiz routes you to other providers serving your state.
How to Cancel MEDVi Without Losing Money
The short answer: Cancel MEDVi at least 72 hours before your next billing date. Submit your request by emailing [email protected] and through the chat feature in your patient portal. Get written confirmation. Watch your statements for the next cycle. MEDVi's published terms state refunds are not issued upon cancellation except in cases of medical disqualification — so once a charge processes, that money is gone.
The MEDVi Cancellation Pitfall Checklist
The 72-hour rule
Cancellation must be received at least 72 hours before your next billing date. If the request isn't received in time, you're charged on the next billing date and cancellation takes effect on the cycle after.
Where to cancel
MEDVi's policy says cancellation requests are accepted by emailing [email protected] or through the chat in your patient portal.
Submit in two places
Send email AND open a chat in your portal. Screenshot both. Belt and suspenders.
Get written confirmation
Ask MEDVi to confirm the effective cancellation date in writing.
The money-back guarantee is separate from cancellation
MEDVi displays a guarantee on its public page, but the exact money-back terms should be verified directly before you rely on them for switch planning. Don't bank on a refund.
Refunds on cancellation are limited
MEDVi's published refund policy states refunds are not issued upon cancellation except in cases of medical disqualification.
Medication already ordered
MEDVi's policy notes that prescription medication generally cannot be returned for refund or reuse once ordered. Ask your clinician how to use, pause, or discontinue any remaining medication during the transition.
Watch your statements
If a post-cancellation charge appears, dispute it through your card issuer immediately. Use your cancellation confirmation email as documentation.
Copy-Paste MEDVi Cancellation Email
Send this at least 72 hours before your next billing date:
Send this. Open a chat in your patient portal too. Screenshot both. Do not skip either step.
What If Your Insurance Doesn't Cover GLP-1s?
The short answer: If your commercial insurance won't cover Wegovy® or Zepbound®, you have three honest paths.
Path 1: Ro cash-pay
Best for: People who specifically want FDA-approved medication and are willing to pay more for it
Cost: ~$188 first month; ~$298–$498/month after, depending on medication and prepay
Tradeoff: Most expensive of the three, but you're on FDA-approved medication backed by the full FDA review process for the finished product
Path 2: Stay on MEDVi (or another compounded provider)
Best for: People whose top priority is the lowest all-in cash price and who are comfortable with the regulatory uncertainty around compounded products
Cost: $179 first month, $299/month flat after (semaglutide)
Tradeoff: You're on a compounded product, not FDA-approved. The FDA's regulatory direction is moving against misleading compounded-GLP-1 marketing — where it lands long-term isn't decided.
Path 3: Medicare GLP-1 Bridge (if you're 65+ and qualify)
Best for: Medicare Part D/MA-PD enrollees meeting CMS clinical criteria
Cost: $50 copay regardless of dose
Tradeoff: Eligibility rules are specific. Coordinate with your Part D plan and prescriber. Ro says it currently can't help coordinate GLP-1 medication coverage for government insurance plans.
When Should You NOT Switch From MEDVi to Ro?
The short answer: Don't switch if your only reason is that Ro "sounds more official" or that the membership fee is lower than MEDVi's flat price. Don't switch if you can't risk a 2–3 week prior authorization wait. Don't switch in the middle of side effects that need clinician guidance. And don't rush a switch when your MEDVi billing date is inside 72 hours.
Bad reason 1: "Ro is cheaper than MEDVi"
It isn't, on cash-pay. MEDVi's $299/month flat covers the medication. Ro's $149/month membership covers nothing but the platform — medication is a separate bill. If you can't budget for the medication on top, the switch won't end well.
Bad reason 2: "I want my insurance to cover it, but I don't know if my plan covers GLP-1s"
Check first. Run Ro's free GLP-1 Insurance Coverage Checker before you sign up. Among firms with 200+ workers, only 19% covered GLP-1 agonists primarily for weight loss in 2025 (KFF). If your plan doesn't have a GLP-1 obesity benefit, the insurance concierge can't conjure coverage — and you'll end up paying full cash-pay through Ro, which is more expensive than MEDVi.
Bad reason 3: "I want to switch fast"
The insurance route at Ro is typically 2–3 weeks of prior auth. Your $149/month membership bills during that window. If speed is your top priority and you're paying cash, Ro's cash-pay route is fast — Ro says you can take your first dose in less than a week once prescribed.
Bad reason 4: "I'm in the middle of side effects"
Talk to a clinician before you switch. Severe nausea, persistent vomiting, signs of dehydration, gallbladder symptoms, or anything alarming is a medical issue, not a provider switch. Get the medical situation stable first.
Not sure? Take the matching quiz
What Our Editorial Team Actually Verified for This Guide
Transparency matters more than slick branding. Here's exactly what we checked, when, and where:
| ✅ Verified May 12, 2026 | Source |
|---|---|
| Ro Body membership pricing ($39 first / $149 monthly / $74 with annual prepay) | ro.co/weight-loss/pricing |
| Ro Wegovy® pill dose-level pricing ($149–$299) and April 15, 2026 price change | ro.co/weight-loss/wegovy-pill-cost |
| Ro Foundayo® dose-level pricing and 45-day refill condition | ro.co/weight-loss/how-to-get-foundayo |
| Ro Zepbound® KwikPen dose-level pricing and 45-day refill condition | ro.co/weight-loss/pricing |
| Ro's insurance concierge process and government-plan exclusions | ro.co/weight-loss/insurance |
| Ro Terms (compounded medication during national shortages) | ro.co/terms-of-use |
| MEDVi semaglutide pricing ($179 first / $299 ongoing) | glp.medvi.org |
| MEDVi cancellation policy (72 hours notice, [email protected] or portal chat) | home.medvi.org/cancellation-and-refund-policy |
| FDA Warning Letter #721455 to MEDVi (Feb 20, 2026) | fda.gov |
| FDA March 3, 2026 announcement of 30 telehealth warning letters | fda.gov |
| FDA April 2026 compounding policy clarification | fda.gov |
| Medicare GLP-1 Bridge eligibility, dates, covered drugs | cms.gov |
| Wegovy® pill OASIS 4 trial efficacy (16.6%) | novonordisk.com |
| Zepbound® SURMOUNT-1 trial efficacy (15.0% / 19.5% / 20.9%) | investor.lilly.com |
| Foundayo® ATTAIN-1 trial efficacy (12.4%) and dosing | investor.lilly.com |
| KFF 2025 Employer Health Benefits Survey (GLP-1 coverage rates) | kff.org |
We did not personally use either platform's medication for this article. Guidance on dose conversion and switch timing is based on FDA labeling and publicly available clinician-facing references. Your prescribing decisions are made by your Ro-affiliated provider.
Affiliate disclosure: We earn a referral fee when readers sign up for Ro or MEDVi through our links. This does not change our editorial conclusions. We tell readers when MEDVi is the better fit even though Ro pays us more on cash-pay traffic — because being right is worth more long-term than being pushy.
Bottom Line
If you've decided to switch from MEDVi to Ro, the playbook is short:
- 1.Find your MEDVi billing date and screenshot it
- 2.Save your MEDVi records — dose history, last dose, side effects, pharmacy
- 3.Start your Ro Body intake while still on MEDVi (about 10 minutes)
- 4.Wait for your Ro provider's plan and your medication
- 5.Cancel MEDVi at least 72 hours before your next billing date — by email to [email protected] AND in your patient portal chat
- 6.Start your Ro medication on the date your provider sets
Total time: ~10–14 days on cash-pay, ~14–28 days on insurance. Ro costs $39 first month, then $149/month ($74/month with annual prepay). Medication is billed separately and ranges from $149/month for Wegovy® pill 1.5 mg or Foundayo® 0.8 mg up to $449+/month for Zepbound® KwikPen at maintenance — unless eligible commercial insurance and manufacturer savings apply, in which case certain medication can be as low as $25/month.
Last verified . We update this page when pricing or policy changes.
Still not sure which GLP-1 program is right for you?
We ask about your current medication, your insurance, your budget, and what matters most to you — then we tell you which GLP-1 program actually fits. Ro, MEDVi, Eden, Sesame Care, or one of the others. No commitment. We don't sell your information.
Take our free 60-second matching quizRelated guides